Two-Dimensional Proton Magnetic Resonance Spectroscopy versus J-Editing for GABA Quantification in Human Brain: Insights from a GABA-Aminotransferase Inhibitor Study

Abstract

Metabolite-specific, scalar spin-spin coupling constant (J)-editing 1H MRS methods have become gold-standard for measuring brain γ-amino butyric acid (GABA) levels in human brain. Localized, two-dimensional (2D) 1H MRS technology offers an attractive alternative as it significantly alleviates the problem of severe metabolite signal overlap associated with standard 1D MRS and retains spectroscopic information for all MRS-detectable species. However, for metabolites found at low concentration, a direct, in vivo, comprehensive methods comparison is challenging and has not been reported to date. Here, we document an assessment of comparability between 2D 1H MRS and J-editing methods for measuring GABA in human brain. This clinical study is unique in that it involved chronic administration a GABA-amino transferase (AT) inhibitor (CPP-115), which induces substantial increases in brain GABA concentration, with normalization after washout. We report a qualitative and quantitative comparison between these two measurement techniques. In general, GABA concentration changes detected using J-editing were closely mirrored by the 2D 1H MRS time courses. The data presented are particularly encouraging considering recent 2D 1H MRS methodological advances are continuing to improve temporal resolution and spatial coverage for achieving whole-brain, multi-metabolite mapping.

Brain effect mechanism of lever positioning manipulation on LDH analgesia based on multimodal MRI: a study protocol

“…At present, prevalent data analysis methods for resting-state fMRI encompass the examination of metrics such as mean amplitude of low-frequency fluctuation (mALFF) [ 21 ], regional homogeneity (ReHo) [ 22 ], and functional connectivity (FC) [ 23 ]. Moreover, magnetic resonance spectroscopy (MRS) represents an additional technical modality within the MRI domain, being the sole non-invasive means for quantitatively detecting alterations in cerebral substances [ 24 , 25 ]. MRS can discern a plethora of compounds within the brain, including N-acetylaspartate (NAA), choline (Cho), creatine (Cr), glutamate (Glu), glutamine (Gln), gamma-aminobutyric acid (GABA), and glucose, among others.…”

Nipecotic-Acid-Tethered, Naphthalene-Diimide-Based, Orange-Emitting Organic Nanoparticles as Targeted Delivery Vehicle and Diagnostic Probe toward GABAA-Receptor-Enriched Cancer Cells

“…Fast inhibitory neurotransmission in the mammalian central nervous system (CNS) is principally mediated by the ubiquitous neurotransmitter GABA (γ-aminobutyric acid) and its synaptic target, the type A GABA receptor (GABA A R). − The GABA A R is a channel-forming protein that decreases the neuronal excitability by allowing the passage of chloride ions into the cells. − A dysfunction in GABA A R signaling triggers various hyperactive neurological disorders and mental illnesses including Alzheimer’s disease, epilepsy, anxiety, and insomnia. − The GABA A R is a prolific target in therapeutics for a diverse array of drugs, including benzodiazepines, barbiturates, anesthetics, and ethanol, that act through distinct binding sites. − Variety of methods have been developed for the detection of GABA, based on in vivo magnetic resonance spectroscopy (MRS), microdialysis, electrochemical and piezoelectric methods, genetically encoded sensor, nanomaterials-based sensor etc. − However, GABA A R-targeted diagnostic methods are still lacking because they have poor spatiotemporal resolution, are time consuming, and have low sensitivity. , Nonetheless, reported methods for the cellular transporting of GABAergic drugs along with cellular imaging/labeling techniques are really scarce. To this end, FONPs can serve as an emerging probe for bioimaging as well as cellular transportation of cargos.…”

High‐resolution, 3D multi‐TE 1H MRSI using fast spatiospectral encoding and subspace imaging

“…However, acquiring MRSI data at multiple TEs introduces an additional imaging dimension, thus resulting in multiplied imaging time. Therefore, current applications of multi‐TE acquisitions are limited to either single‐voxel spectroscopy or very low‐resolution scans with small organ coverage 8,12,13 . The decaying SNR for data acquired at longer TEs and increased sensitivity to system instabilities due to lengthened imaging time are also major limiting factors.…”